Company Analysis
Sign in

NewGenIvf Group Limited (NIVF)

Nasdaq: NIVF · Services-Misc Health & Allied Services, NEC · Bangkok, TH · filing with the SEC since 2023
Full chart Alerts Compare
Grade3.9
◀ Past 3.4● Present 3.7▶ Future 4.6
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$4.7M-13.0%
Net income$9.9M+1983.1%
Earnings per share$3.04+100.1%
Operating cash flow-$10.9M-32.2%
Cash$758,621+65.7%
Debtn/a
Shareholders’ equity$26.0M+1853.8%
Shares, diluted3,250,020+2731009.2%
Return on equity38.0%
The recordfrom its filings
Filings in 202677
Newest filingNov 12 · EFFECT
Annual reportMar 31, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$4.2M
Patents grantedn/a
Filer category<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
2122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
Oct 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton NIVF · research, not advice